EC Neurology

Background: Aneurysmal subarachnoid haemorrhage (SAH) is a prevalent condition, especially in regions such as Latin America, with a global in-hospital mortality rate of 20%. 26% of patients with SAH present with seizures, leading current guidelines to recommend the prophylactic use of antiepileptic drugs (AEDs) in certain situations.

Objectives: To determine the presence of epileptic seizures and the mortality rate in patients hospitalized with a diagnosis of subarachnoid haemorrhage (SAH) secondary to aneurysmal rupture.

Methods: A retrospective analytical observational study was carried out in a cohort of patients hospitalized in our institution with a diagnosis of SAH secondary to aneurysmal rupture who suffered epileptic seizures during hospitalization and the associated mortality rate was analysed in a 5-year period (2020-2024). IBM SPSS^® (v30.0.0) was used for descriptive statistics, Chi-square test (χ²), T-test and ANOVA for group comparison and logistic regression to identify predictors of mortality.

Results: The study included 45 patients, with a predominance of women (73%) with a mean age of 58 years. 29% of patients had epileptic seizures during hospitalization. Overall mortality was 60%, and patients who experienced seizures had a significantly higher mortality rate (85% / p = 0.013) compared to those who did not have seizures.

Conclusion: The results suggest a statistically significant correlation between the presence of epilepsy and mortality in patients with aneurysmal SAH. Although the presence of epileptic seizures in these patients is relatively frequent, this finding underlines the need for further studies to identify specific factors that contribute to increased mortality in this clinical context.

 Keywords: Aneurysmal Rupture; Epilepsy; Mortality; Subarachnoid Haemorrhage; Fisher

1. Hoh BL., et al. “2023 guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association”. Stroke7 (2023): e314-e370.
2. Huang T., et al. “Can the radiomics features of intracranial aneurysms predict the prognosis of aneurysmal subarachnoid hemorrhage?” Frontiers in Neuroscience 18 (2024): 1446784.
3. Tsao CW., et al. “Heart disease and stroke statistics—2023 update: a report from the American Heart Association”. Circulation8 (2023): e93-e621.
4. Wahood W., et al. “Trends in admissions and outcomes for treatment of aneurysmal subarachnoid hemorrhage in the United States”. Neurocritical Care 1 (2022): 209-218.
5. Etminan N., et al. “Worldwide incidence of aneurysmal subarachnoid hemorrhage according to region, time period, blood pressure, and smoking prevalence in the population: a systematic review and meta-analysis”. JAMA Neurology5 (2019): 588-597.
6. Korja M., et al. “Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates”. Neurology11 (2016): 1118-1123.
7. SVIN COVID-19 Global SAH Registry. “Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up”. Journal of Neurology, Neurosurgery and Psychiatry 10 (2022): 1028-1038.
8. Mackey J., et al. “Stable incidence but declining case-fatality rates of subarachnoid hemorrhage in a population”. Neurology21 (2016): 2192-2197.
9. Mahlamäki K., et al. “Case fatality rates of subarachnoid hemorrhage are decreasing with substantial between-country variation: a systematic review of population-based studies between 1980 and 2020”. Neuroepidemiology6 (2022): 402-412.
10. Chen Y., et al. “Duration and choices of prophylactic anticonvulsants in subarachnoid hemorrhage: a systematic review and meta-analysis”. Neurosurgical Review 5 (2021): 2459-2467.
11. Raper DMS., et al. “Seizures after aneurysmal subarachnoid hemorrhage: a systematic review of outcomes”. World Neurosurgery5-6 (2013): 682-690.
12. Claassen J., et al. “Predictors and clinical impact of epilepsy after subarachnoid hemorrhage”. Neurology2 (2003): 208-214.
13. Hunt WE and Hess RM. “Surgical risk as related to time of intervention in the repair of intracranial aneurysms”. Journal of Neurosurgery 1 (1968): 14-20.
14. Fisher CM., et al. “Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning”. Neurosurgery1 (1980): 1-9.
15. Bederson JB., et al. “Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American Heart Association”. Stroke3 (2009): 994-1025.
16. Connolly ES., et al. “Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association”. Stroke6 (2012): 1711-1737.
17. Dubosh NM., et al. “Sensitivity of early brain computed tomography to exclude aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis”. Stroke3 (2016): 750-755.
18. Godwin SA., et al. “Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with acute headache”. Annals of Emergency Medicine 4 (2019): e41-e74.
19. Fisher RS., et al. “Operational classification of seizure types by the International league against epilepsy: position paper of the ILAE commission for classification and terminology”. Epilepsia4 (2017): 522-530.
20. Wirrell E., et al. “Introduction to the epilepsy syndrome papers”. Epilepsia6 (2022): 1330-1332.
21. Fang Y., et al. “Comparison of aneurysmal subarachnoid hemorrhage grading scores in patients with aneurysm clipping and coiling”. Scientific Reports 1 (2020): 9199.
22. Claassen J., et al. “Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome”. Stroke5 (2002): 1225-1232.
23. Mooij JJA. “Grading and decision-making in (aneurysmal) subarachnoid haemorrhage”. Interventional Neuroradiology 4 (2001): 283-289.
24. Ransom ER., et al. “External ventricular drainage response in poor grade aneurysmal subarachnoid hemorrhage: effect on preoperative grading and prognosis”. Neurocritical Care 3 (2007): 174-180.
25. Chen HY., et al. “Combining transcranial doppler and EEG data to predict delayed cerebral ischemia after subarachnoid hemorrhage”. Neurology5 (2022): e459-e469.
26. Mocco J., et al. “Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage”. Neurosurgery3 (2006): 529-538.
27. Proust F., et al. “A randomized controlled study assessing outcome, cognition, autonomy and quality of life in over 70-year-old patients after aneurysmal subarachnoid hemorrhage”. Neurochirurgie6 (2018): 395-400.
28. Juvela S and Siironen J. “Early cerebral infarction as a risk factor for poor outcome after aneurysmal subarachnoid haemorrhage”. European Journal of Neurology 2 (2012): 332-339.
29. Matsuda S., et al. “Recent declining trend of incidence rate of subarachnoid hemorrhage in Shimane, Japan: The Japan incidence of subarachnoid hemorrhage (JIS) study”. Neurologia Medico-Chirurgica (Tokyo)10 (2022): 458-464.
30. Xia C., et al. “Trends in the incidence of spontaneous subarachnoid hemorrhages in the United States, 2007-2017”. Neurology2 (2023): e123-e132.
31. Catapano JS., et al. “Long-term independence in older patients with aneurysmal subarachnoid hemorrhage in the barrow ruptured aneurysm trial”. World Neurosurgery 147 (2021): e98-104.
32. Perry JJ., et al. “Clinical decision rules to rule out subarachnoid hemorrhage for acute headache”. Journal of the American Medical Association12 (2013): 1248-1255.
33. Kowalski RG. “Initial misdiagnosis and outcome after subarachnoid hemorrhage”. Journal of the American Medical Association 7 (2004): 866-869.
34. Angriman F., et al. “Antiepileptic drugs to prevent seizures after spontaneous intracerebral hemorrhage: a systematic review and meta-analysis”. Stroke5 (2019): 1095-1099.
35. Panczykowski D., et al. “Prophylactic antiepileptics and seizure incidence following subarachnoid hemorrhage: a propensity score-matched analysis”. Stroke 7 (2016): 1754-1760.
36. Szaflarski JP., et al. “Prospective, randomized, single-blinded comparative trial of intravenous levetiracetam versus phenytoin for seizure prophylaxis”. Neurocritical Care 2 (2010): 165-172.
37. Murphy-Human T., et al. “Comparison of short-duration levetiracetam with extended-course phenytoin for seizure prophylaxis after subarachnoid hemorrhage”. World Neurosurgery 2 (2011): 269-274.
38. Thamjamrassri T., et al. “A narrative review of the published literature, hospital practices, and policies related to external ventricular drains in the United States: The external ventricular drain publications, practices, and policies (EVDPoP) study”. Journal of Neurosurgical Anesthesiology 1 (2022): 21-28.